Anixa Biosciences, Inc. (ANIX)
NASDAQ: ANIX · Real-Time Price · USD
3.010
-0.050 (-1.63%)
At close: Aug 1, 2025, 4:00 PM
3.100
+0.090 (2.99%)
After-hours: Aug 1, 2025, 7:12 PM EDT

Anixa Biosciences Ratios and Metrics

Millions USD. Fiscal year is Nov - Oct.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Aug '25 Oct '24 Oct '23 Oct '22 Oct '21 Oct '20 2016 - 2020
971139817214349
Upgrade
Market Cap Growth
-5.19%14.71%-42.82%20.19%191.52%-37.33%
Upgrade
Enterprise Value
82917213910640
Upgrade
Last Close Price
3.013.503.165.604.772.06
Upgrade
PS Ratio
--467.53-279.02-
Upgrade
PB Ratio
6.035.964.206.094.115.93
Upgrade
P/TBV Ratio
6.035.634.035.914.035.59
Upgrade
EV/Sales Ratio
--342.38-206.32-
Upgrade
Debt / Equity Ratio
0.020.010.010.010.010.01
Upgrade
Asset Turnover
--0.01-0.02-
Upgrade
Quick Ratio
8.278.0411.8914.6028.137.62
Upgrade
Current Ratio
8.898.5512.5014.8328.357.88
Upgrade
Return on Equity (ROE)
-65.38%-60.10%-38.51%-43.74%-61.02%-154.36%
Upgrade
Return on Assets (ROA)
-39.75%-36.70%-24.61%-26.02%-35.92%-81.88%
Upgrade
Return on Capital (ROIC)
-43.40%-40.52%-26.48%-27.34%-37.88%-98.19%
Upgrade
Earnings Yield
-12.52%-11.15%-9.99%-7.92%-9.07%-20.44%
Upgrade
FCF Yield
-8.23%-6.51%-6.32%-3.78%-3.46%-12.63%
Upgrade
Buyback Yield / Dilution
-2.56%-2.96%-1.99%-6.28%-28.57%-12.33%
Upgrade
Updated Mar 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q